A randomized, single-center, placebo controlled study to assess the safety of UT-15C(treprostinil diethanolamine) sustained release (SR) in patients undergoing an infra-popliteal endovascular intervention for the treatment of critical limb ischemia

Trial Profile

A randomized, single-center, placebo controlled study to assess the safety of UT-15C(treprostinil diethanolamine) sustained release (SR) in patients undergoing an infra-popliteal endovascular intervention for the treatment of critical limb ischemia

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Nov 2016

At a glance

  • Drugs Treprostinil (Primary)
  • Indications Vascular restenosis
  • Focus Adverse reactions
  • Most Recent Events

    • 13 May 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
    • 13 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top